MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 563 SEK 3.68% Market Closed
Market Cap: 8.3B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

Intrinsic Value

The intrinsic value of one MCAP stock under the Base Case scenario is 423.54 SEK. Compared to the current market price of 563 SEK, MedCap AB (publ) is Overvalued by 25%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MCAP Intrinsic Value
423.54 SEK
Overvaluation 25%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
MedCap AB (publ)

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MCAP cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MCAP?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about MedCap AB (publ)

Provide an overview of the primary business activities
of MedCap AB (publ).

What unique competitive advantages
does MedCap AB (publ) hold over its rivals?

What risks and challenges
does MedCap AB (publ) face in the near future?

Has there been any significant insider trading activity
in MedCap AB (publ) recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for MedCap AB (publ).

Provide P/S
for MedCap AB (publ).

Provide P/E
for MedCap AB (publ).

Provide P/OCF
for MedCap AB (publ).

Provide P/FCFE
for MedCap AB (publ).

Provide P/B
for MedCap AB (publ).

Provide EV/S
for MedCap AB (publ).

Provide EV/GP
for MedCap AB (publ).

Provide EV/EBITDA
for MedCap AB (publ).

Provide EV/EBIT
for MedCap AB (publ).

Provide EV/OCF
for MedCap AB (publ).

Provide EV/FCFF
for MedCap AB (publ).

Provide EV/IC
for MedCap AB (publ).

Show me price targets
for MedCap AB (publ) made by professional analysts.

What are the Revenue projections
for MedCap AB (publ)?

How accurate were the past Revenue estimates
for MedCap AB (publ)?

What are the Net Income projections
for MedCap AB (publ)?

How accurate were the past Net Income estimates
for MedCap AB (publ)?

What are the EPS projections
for MedCap AB (publ)?

How accurate were the past EPS estimates
for MedCap AB (publ)?

What are the EBIT projections
for MedCap AB (publ)?

How accurate were the past EBIT estimates
for MedCap AB (publ)?

Compare the revenue forecasts
for MedCap AB (publ) with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of MedCap AB (publ) and its key competitors using the latest financial data.

Compare historical revenue growth rates
of MedCap AB (publ) against its competitors.

Analyze the profit margins
(gross, operating, and net) of MedCap AB (publ) compared to its peers.

Compare the P/E ratios
of MedCap AB (publ) against its peers.

Discuss the investment returns and shareholder value creation
comparing MedCap AB (publ) with its peers.

Analyze the financial leverage
of MedCap AB (publ) compared to its main competitors.

Show all profitability ratios
for MedCap AB (publ).

Provide ROE
for MedCap AB (publ).

Provide ROA
for MedCap AB (publ).

Provide ROIC
for MedCap AB (publ).

Provide ROCE
for MedCap AB (publ).

Provide Gross Margin
for MedCap AB (publ).

Provide Operating Margin
for MedCap AB (publ).

Provide Net Margin
for MedCap AB (publ).

Provide FCF Margin
for MedCap AB (publ).

Show all solvency ratios
for MedCap AB (publ).

Provide D/E Ratio
for MedCap AB (publ).

Provide D/A Ratio
for MedCap AB (publ).

Provide Interest Coverage Ratio
for MedCap AB (publ).

Provide Altman Z-Score Ratio
for MedCap AB (publ).

Provide Quick Ratio
for MedCap AB (publ).

Provide Current Ratio
for MedCap AB (publ).

Provide Cash Ratio
for MedCap AB (publ).

What is the historical Revenue growth
over the last 5 years for MedCap AB (publ)?

What is the historical Net Income growth
over the last 5 years for MedCap AB (publ)?

What is the current Free Cash Flow
of MedCap AB (publ)?

Discuss the annual earnings per share (EPS)
trend over the past five years for MedCap AB (publ).

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
MedCap AB (publ)

Current Assets 873.7m
Cash & Short-Term Investments 287.7m
Receivables 319.1m
Other Current Assets 266.9m
Non-Current Assets 1B
Long-Term Investments 500k
PP&E 382.6m
Intangibles 630.7m
Other Non-Current Assets 6.6m
Current Liabilities 331.9m
Accounts Payable 238.6m
Other Current Liabilities 93.3m
Non-Current Liabilities 369m
Long-Term Debt 296.1m
Other Non-Current Liabilities 72.9m
Efficiency

Earnings Waterfall
MedCap AB (publ)

Revenue
1.8B SEK
Cost of Revenue
-954.9m SEK
Gross Profit
834.2m SEK
Operating Expenses
-539.9m SEK
Operating Income
294.3m SEK
Other Expenses
-66.4m SEK
Net Income
227.9m SEK

Free Cash Flow Analysis
MedCap AB (publ)

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MCAP Profitability Score
Profitability Due Diligence

MedCap AB (publ)'s profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Free Cash Flow
Positive 3-Year Average ROE
62/100
Profitability
Score

MedCap AB (publ)'s profitability score is 62/100. The higher the profitability score, the more profitable the company is.

MCAP Solvency Score
Solvency Due Diligence

MedCap AB (publ)'s solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
85/100
Solvency
Score

MedCap AB (publ)'s solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MCAP Price Targets Summary
MedCap AB (publ)

Wall Street analysts forecast MCAP stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MCAP is 545.7 SEK with a low forecast of 540.35 SEK and a high forecast of 561.75 SEK.

Lowest
Price Target
540.35 SEK
4% Downside
Average
Price Target
545.7 SEK
3% Downside
Highest
Price Target
561.75 SEK
0% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MCAP?

Click here to dive deeper.

Dividends

MedCap AB (publ)
does not pay dividends
Shareholder Yield

Current shareholder yield for MCAP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MCAP Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

MedCap AB (publ) Logo
MedCap AB (publ)

Country

Sweden

Industry

Life Sciences Tools & Services

Market Cap

8.3B SEK

Dividend Yield

0%

Description

MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Solna, Stockholm. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.

Contact

STOCKHOLM
Solna
Sundbybergsvagen 1
+468347110
www.medcap.se

IPO

2006-07-04

Employees

375

Officers

Chief Executive Officer
Mr. Anders Dahlberg
Chief Financial Officer
Ms. Kristina Ekblad
Investment Manager
Mr. Lars Ă…ngman

See Also

Discover More
What is the Intrinsic Value of one MCAP stock?

The intrinsic value of one MCAP stock under the Base Case scenario is 423.54 SEK.

Is MCAP stock undervalued or overvalued?

Compared to the current market price of 563 SEK, MedCap AB (publ) is Overvalued by 25%.

Back to Top